Skip to main content

Global AI in Medical Imaging Market to register 28% CAGR with digital health boost by 2030

 


The global AI in medical imaging market is set to witness a growth rate of ~28% in the next 5 years. Rising prevalence of chronic diseases and increasing imaging workload; surge in big data driven by digital transformation and widespread use of information systems; advancements in deep learning and AI algorithms; integration with PACS and cloud-based imaging solutions; government and private investments in AI healthcare; growing adoption of AI for personalized medicine; and increasing funding opportunities for AI-focused startups are some of the key factors driving the AI in medical imaging market. 

AI in medical imaging refers to the integration of artificial intelligence technologies, including machine learning and deep learning, to enhance the analysis, interpretation, and diagnosis of medical images. It automates image processing, detects patterns, and assists radiologists in identifying diseases such as cancer, neurological disorders, and cardiovascular conditions with greater accuracy and efficiency. AI-powered imaging solutions improve workflow efficiency, reduce diagnostic errors, and enable early disease detection. These technologies integrate with Picture Archiving and Communication Systems (PACS) and cloud platforms, facilitating remote diagnostics. AI in medical imaging is revolutionizing healthcare by optimizing precision medicine, reducing workload, and enhancing patient outcomes.

Download a free sample report now 👉
https://meditechinsights.com/ai-in-medical-imaging-market/request-sample/

Rising prevalence of chronic diseases and increasing imaging workload to propel market demand

The rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, has significantly increased the demand for medical imaging. This surge in imaging procedures has placed immense pressure on radiologists, leading to increased workload and the risk of diagnostic errors. AI-driven medical imaging solutions help address this challenge by automating image analysis, detecting abnormalities with high accuracy, and streamlining workflows. By reducing radiologists' burden and improving diagnostic efficiency, AI enhances early disease detection and treatment planning. As healthcare providers seek to optimize resources and improve patient outcomes, AI adoption in medical imaging continues to accelerate.

Increasing funding opportunities for AI-focused startups are driving the market growth

Rising investments in AI-focused startups are driving innovation in medical imaging, improving diagnostic accuracy, workflow automation, and early disease detection. Funding from venture capital and government grants enables companies to refine AI solutions and expand clinical applications. Startups like Flywheel (US $54M Series D in 2023), Gleamer (US $27M Series B in 2023), Gradient Health (US $2.5M seed in 2022), and Qure.ai (US $40M funding in 2022) are leading advancements in AI-driven diagnostics. Industry giants Google, GE, and Philips are integrating AI into imaging tools, with Google Cloud enhancing cancer prediction and GE & Philips upgrading MRI, CT, and X-ray systems, optimizing radiology workflows and patient outcomes. These investments enable startups to refine their technology, obtain regulatory approvals, and expand market reach.

Competitive Landscape Analysis

The global AI in medical imaging market is marked by the presence of established and emerging market players such as Microsoft Corporation, Koninklijke Philips N.V., Siemens Healthineers, GE Healthcare, Merative, Google (Alphabet Inc.), Canon Medical Systems Corporation, Fujifilm Holdings, Advanced Micro Devices, Inc., and Enlitic Inc; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

 Download a sample report for in-depth competitive insights
https://meditechinsights.com/ai-in-medical-imaging-market/request-sample/

Global AI In Medical Imaging Market Segmentation

This report by Medi-Tech Insights provides the size of the global AI in medical imaging market at the regional- and country-level from 2023 to 2030. The report further segments the market based on component, modality, application, end user.

Market Size & Forecast (2023-2030), By Component, USD Million

  • Software
  • Service

Market Size & Forecast (2023-2030), By Modality, USD Million

  • X-ray
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Others

Market Size & Forecast (2023-2030), By Application, USD Million

  • Oncology
  • Neurology
  • Cardiology
  • Obstetrics and Gynaecology
  • Ophthalmology
  • Orthopaedics
  • Gastroenterology
  • Others

Market Size & Forecast (2023-2030), By End User, USD Million

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more